Company Filing History:
1 out of 5 
1 out of 8 Years Active: 2023
Title: Johan Franciscus Adrianus Pijnenborg: Innovator in Sialyltransferase Inhibitors
Introduction
Johan Franciscus Adrianus Pijnenborg is a notable inventor based in Nijmegen, Netherlands. He has made significant contributions to the field of biochemistry, particularly in the development of sialyltransferase inhibitors. His work has implications for treating various medical conditions, showcasing the intersection of innovation and healthcare.
Latest Patents
Pijnenborg holds a patent for "Potent sialyltransferase inhibitors." This invention relates to a new class of sialyltransferase inhibitors featuring a carbamate or similar moiety on the amine of a neuraminic acid derivative. These inhibitors are suitable for use as a medicament, particularly for treating, preventing, or delaying bacterial infections, viral infections, cancer, disorders of sialic acid metabolism, or autoimmune diseases. He has 1 patent to his name.
Career Highlights
Throughout his career, Pijnenborg has been associated with prestigious institutions such as Radboud University and Radboud University Medical Center. His work in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Pijnenborg has worked alongside notable colleagues, including Thomas Jan Boltje and Torben Heise. Their collaborative efforts have further advanced the research and development of innovative medical solutions.
Conclusion
Johan Franciscus Adrianus Pijnenborg is a distinguished inventor whose work in sialyltransferase inhibitors has the potential to impact various medical fields. His contributions reflect the importance of innovation in addressing complex health challenges.